Page last updated: 2024-09-05

aminopterin and Dermatitis Medicamentosa

aminopterin has been researched along with Dermatitis Medicamentosa in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grossman, ME; Husain, S; MacGregor-Cortelli, B; Marneros, AG; Neylon, E; Nuovo, GJ; O'Connor, OA; Patterson, M; Silvers, DN; Zain, JM1
Bartlett, NL; Delioukina, ML; Duvic, M; Fisher, DC; Foss, F; Horwitz, SM; Kim, YH; Koutsoukos, T; Lechowicz, MJ; Myskowski, PL; O'Connor, OA; Saunders, ME; Shustov, AR; Zain, JM1
Adams, L; Boland, J; Hewitt, LA; Jurcevic, S; Mant, T; Szakacs, C1
Campbell, DL; Perez, EA; Ryu, JK1
Almeyda, J; Levantine, A1

Reviews

1 review(s) available for aminopterin and Dermatitis Medicamentosa

ArticleYear
Drug reactions. XXIV. Cutaneous reactions to cytostatic agents.
    The British journal of dermatology, 1974, Volume: 90, Issue:2

    Topics: Alopecia; Aminopterin; Antineoplastic Agents; Asparaginase; Azathioprine; Bleomycin; Busulfan; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Eruptions; Erythema; Fluorouracil; Gynecomastia; Humans; Hydroxyurea; Methotrexate; Photosensitivity Disorders; Pigmentation Disorders; Radiation Injuries; Stomatitis; Vinblastine

1974

Trials

2 trial(s) available for aminopterin and Dermatitis Medicamentosa

ArticleYear
Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma.
    Blood, 2012, May-03, Volume: 119, Issue:18

    Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antimetabolites, Antineoplastic; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Eruptions; Fatigue; Female; Gastrointestinal Diseases; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mucositis; Neutropenia; Salvage Therapy; Skin Neoplasms; Thrombocytopenia

2012
Two single-center, double-blind, randomized, placebo-controlled, phase I studies to investigate the tolerability and pharmacokinetics of CH-1504, an antifolate, in healthy male subjects.
    Clinical therapeutics, 2008, Volume: 30, Issue:1

    Topics: Adult; Aminopterin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Eruptions; Folic Acid Antagonists; Humans; Male; Molecular Structure

2008

Other Studies

2 other study(ies) available for aminopterin and Dermatitis Medicamentosa

ArticleYear
Pralatrexate-induced tumor cell apoptosis in the epidermis of a patient with HTLV-1 adult T-cell lymphoma/leukemia causing skin erosions.
    Blood, 2009, Jun-18, Volume: 113, Issue:25

    Topics: Adult; Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biopsy; Cyclophosphamide; Diagnosis, Differential; Disease Progression; Doxorubicin; Drug Eruptions; Epidermis; Etoposide; Exanthema; Folic Acid Antagonists; Humans; Interferon alpha-2; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Prednisone; Recombinant Proteins; Vincristine; Zidovudine

2009
Radiation recall dermatitis induced by edatrexate in a patient with breast cancer.
    Cancer investigation, 1995, Volume: 13, Issue:6

    Topics: Adult; Aminopterin; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Combined Modality Therapy; Drug Eruptions; Female; Humans; Radiodermatitis

1995